Т. О. Кабилова

406 total citations
22 papers, 329 citations indexed

About

Т. О. Кабилова is a scholar working on Molecular Biology, Immunology and Biomaterials. According to data from OpenAlex, Т. О. Кабилова has authored 22 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Immunology and 4 papers in Biomaterials. Recurrent topics in Т. О. Кабилова's work include RNA Interference and Gene Delivery (20 papers), Advanced biosensing and bioanalysis techniques (9 papers) and interferon and immune responses (7 papers). Т. О. Кабилова is often cited by papers focused on RNA Interference and Gene Delivery (20 papers), Advanced biosensing and bioanalysis techniques (9 papers) and interferon and immune responses (7 papers). Т. О. Кабилова collaborates with scholars based in Russia and Germany. Т. О. Кабилова's co-authors include Marina A. Zenkova, Valentin V. Vlassov, Elena L. Chernolovskaya, М. А. Маслов, Н. Г. Морозова, Elena V. Shmendel, Aleksandra V. Sen’kova, Н. А. Попова, Oleg V. Markov and Mariya I. Meschaninova and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and Annals of the New York Academy of Sciences.

In The Last Decade

Т. О. Кабилова

22 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Т. О. Кабилова Russia 11 298 90 59 55 45 22 329
Elena V. Shmendel Russia 11 320 1.1× 72 0.8× 40 0.7× 76 1.4× 37 0.8× 35 369
Yifei Zhao China 8 183 0.6× 79 0.9× 38 0.6× 27 0.5× 32 0.7× 12 327
Katie Sanders United States 8 315 1.1× 30 0.3× 58 1.0× 36 0.7× 50 1.1× 13 385
Muhammad Moazzam Pakistan 5 260 0.9× 38 0.4× 58 1.0× 40 0.7× 20 0.4× 13 355
Ivan V. Chernikov Russia 10 420 1.4× 49 0.5× 106 1.8× 41 0.7× 33 0.7× 24 487
Katarina Farkasova Germany 5 369 1.2× 48 0.5× 51 0.9× 78 1.4× 67 1.5× 5 430
Mehrdad Dirin Austria 6 334 1.1× 29 0.3× 57 1.0× 50 0.9× 36 0.8× 6 373
Melanie Fechtner 3 490 1.6× 38 0.4× 174 2.9× 63 1.1× 80 1.8× 3 531
Maxime Gestin Sweden 7 279 0.9× 41 0.5× 20 0.3× 38 0.7× 42 0.9× 14 320
Yu-Hung Huang United States 6 251 0.8× 20 0.2× 66 1.1× 58 1.1× 69 1.5× 8 350

Countries citing papers authored by Т. О. Кабилова

Since Specialization
Citations

This map shows the geographic impact of Т. О. Кабилова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Т. О. Кабилова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Т. О. Кабилова more than expected).

Fields of papers citing papers by Т. О. Кабилова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Т. О. Кабилова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Т. О. Кабилова. The network helps show where Т. О. Кабилова may publish in the future.

Co-authorship network of co-authors of Т. О. Кабилова

This figure shows the co-authorship network connecting the top 25 collaborators of Т. О. Кабилова. A scholar is included among the top collaborators of Т. О. Кабилова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Т. О. Кабилова. Т. О. Кабилова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sen’kova, Aleksandra V., Ivan V. Chernikov, Т. О. Кабилова, et al.. (2021). Folate-Equipped Cationic Liposomes Deliver Anti-MDR1-siRNA to the Tumor and Increase the Efficiency of Chemotherapy. Pharmaceutics. 13(8). 1252–1252. 16 indexed citations
2.
Sen’kova, Aleksandra V., Innokenty A. Savin, Т. О. Кабилова, et al.. (2020). Immunostimulating RNA Delivered by P1500 PEGylated Cationic Liposomes Limits Influenza Infection in C57Bl/6 Mice. Pharmaceutics. 12(9). 875–875. 6 indexed citations
4.
Sen’kova, Aleksandra V., Innokenty A. Savin, Т. О. Кабилова, Marina A. Zenkova, & Elena L. Chernolovskaya. (2020). Tumor-Suppressing, Immunostimulating, and Hepatotoxic Effects of Immunostimulatory RNA in Combination with Dacarbazine in a Murine Melanoma Model. Molecular Biology. 54(2). 233–242. 1 indexed citations
5.
Shmendel, Elena V., Т. О. Кабилова, Н. Г. Морозова, Marina A. Zenkova, & М. А. Маслов. (2019). Targeted Delivery of Nucleic Acids by Folate-Containing Liposomes into KB-3-1 and HEK 293 Cells. Russian Journal of Bioorganic Chemistry. 45(6). 719–725. 5 indexed citations
6.
Кабилова, Т. О., Elena V. Shmendel, Н. Г. Морозова, et al.. (2018). Novel PEGylated Liposomes Enhance Immunostimulating Activity of isRNA. Molecules. 23(12). 3101–3101. 15 indexed citations
7.
Степанов, Г. А., Victoria О. Shender, Vladimir V. Koval, et al.. (2018). Nucleotide Modifications Decrease Innate Immune Response Induced by Synthetic Analogs of snRNAs and snoRNAs. Genes. 9(11). 531–531. 33 indexed citations
8.
Кабилова, Т. О., Elena V. Shmendel, Elena L. Chernolovskaya, et al.. (2017). Targeted delivery of nucleic acids into xenograft tumors mediated by novel folate-equipped liposomes. European Journal of Pharmaceutics and Biopharmaceutics. 123. 59–70. 38 indexed citations
9.
Кабилова, Т. О., et al.. (2017). Polycationic amphiphiles based on triethylenetetramine and their transfection efficacy. Russian Journal of Bioorganic Chemistry. 43(5). 561–569. 7 indexed citations
10.
Кабилова, Т. О., Mariya I. Meschaninova, A. G. Venyaminova, et al.. (2017). Impact of chemical modifications in the structure of isRNA on its antiproliferative and immunostimulatory properties. Russian Journal of Bioorganic Chemistry. 43(1). 50–57. 3 indexed citations
11.
Кабилова, Т. О., Aleksandra V. Sen’kova, В. П. Николин, et al.. (2016). Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice. PLoS ONE. 11(3). e0150751–e0150751. 21 indexed citations
12.
Кабилова, Т. О., Larisa V. Kovtonyuk, E. I. Ryabchikova, et al.. (2014). Immunotherapy of hepatocellular carcinoma with small double-stranded RNA. BMC Cancer. 14(1). 338–338. 20 indexed citations
13.
Ivanova, Ekaterina A., М. А. Маслов, Т. О. Кабилова, et al.. (2013). Structure–transfection activity relationships in a series of novel cationic lipids with heterocyclic head-groups. Organic & Biomolecular Chemistry. 11(41). 7164–7164. 12 indexed citations
14.
Кабилова, Т. О., Mariya I. Meschaninova, A. G. Venyaminova, et al.. (2012). Short Double-Stranded RNA with Immunostimulatory Activity: Sequence Dependence. Nucleic Acid Therapeutics. 22(3). 196–204. 28 indexed citations
15.
Маслов, М. А., et al.. (2011). Novel cholesterol spermine conjugates provide efficient cellular delivery of plasmid DNA and small interfering RNA. Journal of Controlled Release. 160(2). 182–193. 69 indexed citations
16.
Кабилова, Т. О., et al.. (2011). Antiproliferative and interferon-inducing activities of unique short double-stranded RNA. Doklady Biochemistry and Biophysics. 436(1). 8–11. 6 indexed citations
17.
Кабилова, Т. О., et al.. (2009). Inhibition of Human Cancer-Cell Proliferation by Long Double-Stranded RNAs. Oligonucleotides. 19(1). 31–40. 6 indexed citations
18.
Кабилова, Т. О., et al.. (2006). Inhibition of Human Carcinoma and Neuroblastoma Cell Proliferation by Anti-c- myc siRNA. Oligonucleotides. 16(1). 15–25. 13 indexed citations
19.
Кабилова, Т. О., et al.. (2006). Arrest of Cancer Cell Proliferation by dsRNAs. Annals of the New York Academy of Sciences. 1091(1). 425–436. 8 indexed citations
20.
Кабилова, Т. О., et al.. (2004). Silencing of c‐myc Expression in Tumor Cells by siRNA. Nucleosides Nucleotides & Nucleic Acids. 23(6-7). 867–872. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026